Sharma East India Hospitals and Medical Research Ltd has filed its annual report for FY26 and scheduled its 37th Annual General Meeting (AGM) for September 30, 2026. The Board of Directors concluded its meeting on September 8, 2026, approving the financial statements and key administrative resolutions.

The AGM will be held via Video Conferencing or Other Audio-Visual Means (OAVM) at 3:00 pm. The primary agenda includes the adoption of the Audited Financial Statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.

Financial Performance

The company reported a total income of ₹3,608.91 lakh for FY26, an increase from ₹3,018.59 lakh in FY25. Revenue from operations stood at ₹3,593.30 lakh, up from ₹2,987.20 lakh in the previous year.

Profit before tax rose to ₹156.42 lakh from ₹141.28 lakh in FY25. Net profit after tax was reported at ₹124.27 lakh, compared to ₹124.43 lakh in FY25. Earnings per share (basic and diluted) remained stable at ₹3.78 per share, down slightly from ₹3.79 per share in the prior year.

Key Approvals and Agenda

The board meeting resulted in several critical approvals:

• Approval of the Director’s Report and related annexures for FY26.
• Approval of the Annual Report for FY25-26 and the Notice of the 37th AGM.
• Re-appointment of Radhika Sathe (DIN: 10645753) as a director, liable to retire by rotation.
• Determination of a fee to be charged from members for delivery of documents in their desired mode, proposed at ₹50.00 per document.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted the notice to BSE Limited. The notice is also available on the company’s website.

Shareholder Logistics

Shareholders must note the following dates for e-voting and record-keeping:

The Register of Members and Share Transfer Books will remain closed from September 24, 2026, to September 30, 2026, inclusive. No dividend was recommended for the year under review, as the board considered it financially prudent to reinvest profits into the business.

Sharma East India Hospitals and Medical Research Ltd has closed its trading window for designated persons effective July 1, 2026, in preparation for the release of its standalone unaudited financial results for the quarter ended June 30, 2026. This measure is implemented to prevent insider trading and ensure market integrity during the sensitive period surrounding financial disclosures. The restriction applies to all individuals with access to unpublished price-sensitive information (UPSI).

The closure follows the regulations outlined in the BSE Circular dated April 2, 2019 (Ref No: LIST/COMP/01/2019-20). The company communicated this decision to the Department of Corporate Service at BSE Limited to formally record the compliance measure. The trading window will remain shut until the financial results are made public.

According to the filing, the window is scheduled to reopen 48 hours after the announcement of the standalone unaudited financial results for the quarter ended June 30, 2026, becomes generally available. This interval allows the market to absorb the information before designated persons resume trading activities.

The intimation was signed by Bhawana Sharma, the Company Secretary and Compliance Officer, on behalf of the company. The communication was addressed to the BSE Limited office in Mumbai, confirming the adherence to regulatory protocols.